Krebs Biochem

3
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE268B01013
  • NSEID: KREBSBIO
  • BSEID: 524518
INR
68.97
3.69 (5.65%)
BSENSE

Dec 05

BSE+NSE Vol: 3.07 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -14.10% vs -3.29% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -72.28% vs 44.72% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 26.12% vs 57.72% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -36.55% vs 20.10% in Mar 2024

Compare Profit and Loss Results of Krebs Biochem
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
43.00
103.00
-60.00
-58.25%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
43.00
103.00
-60.00
-58.25%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-4.00
7.00
175.00%
Raw Materials Consumed
2.00
83.00
-81.00
-97.59%
Power & Fuel Cost
18.00
0.00
18.00
0%
Employee Cost
16.00
4.00
12.00
300.00%
Operating Expenses
12.00
0.00
12.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
2.00
-2.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
58.00
87.00
-29.00
-33.33%
Operating Profit (PBDIT) excl Other Income
-15.00
15.00
-30.00
-200.00%
Other Income
0.00
4.00
-4.00
-100.00%
Operating Profit (PBDIT)
-14.00
20.00
-34.00
-170.00%
Interest
5.00
0.00
5.00
0%
Profit before Depriciation and Tax
-20.00
19.00
-39.00
-205.26%
Depreciation
6.00
0.00
6.00
0%
Profit Before Taxation & Exceptional Items
-26.00
18.00
-44.00
-244.44%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-26.00
18.00
-44.00
-244.44%
Provision for Tax
0.00
5.00
-5.00
-100.00%
Profit After Tax
-26.00
13.00
-39.00
-300.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-270.00
14.00
-284.00
-2,028.57%
Profit Available for appropriations
-297.00
27.00
-324.00
-1,200.00%
Appropriations
-297.00
27.00
-324.00
-1,200.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-12.49
8.28
-20.77
-250.85%
Profit And Loss - Net Sales
Net Sales 43.31 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -14.10% vs -3.29% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -15.03 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -72.28% vs 44.72% in Mar 2024

Profit And Loss - Interest
Interest 5.91 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 26.12% vs 57.72% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax -26.94 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -36.55% vs 20.10% in Mar 2024